Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Pediatr Endocrinol Diabetes Metab ; 27(4): 298-304, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34928109

RESUMEN

The coexistence of 2 genetic diseases can mutually modify their course. We describe the case of a 10-year-old boy with Sliver-Russell syndrome (SRS) and Duchenne muscular dystrophy (DMD). The patient's short stature, which is part of the clinical picture of both diseases, has been additionally aggravated by the steroid therapy, which is necessary to delay the progression of DMD. From the age of 9 years, the patient was treated with recombinant human growth hormone (rhGH) for 18 months. The following study discusses whether rhGH therapy in a child with SRS and DMD may alleviate or worsen the course of DMD, and how it affects carbohydrate metabolism disorders.


Asunto(s)
Distrofia Muscular de Duchenne , Síndrome de Silver-Russell , Estatura , Niño , Glucocorticoides , Humanos , Masculino , Fuerza Muscular , Distrofia Muscular de Duchenne/complicaciones , Distrofia Muscular de Duchenne/tratamiento farmacológico , Distrofia Muscular de Duchenne/genética , Síndrome de Silver-Russell/tratamiento farmacológico , Síndrome de Silver-Russell/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA